Medipass - Ergéa Group’s Post

View profile for Alba Fiorentino, graphic

Associate Professor of Radiation Oncology LUM University of Medicine, Chief of Diagnostic and Therapeutic Department, Chief of Radiation Oncology MIULLI.art H-index 30

https://lnkd.in/dkZe98W3 Technically, adult craniospinal irradiation (CSI) cases are different and more complex than pediatric cases due to the length of the craniospinal axis (40–50 cm for children versus 65–75 cm for adults) and the greater body mass index of adults. VMAT tailors the dose for better uniformity over the CSI, reducing the dose to organs at risk (OARs). Due to the rarity of the disease in adult patients, more research needs to be done on dosimetric data and inter-fraction reproducibility for CSI in AMB patients. This retrospective analysis addresses this gap by examining the treatment outcomes related to dosimetric data, inter-fraction reproducibility, and clinical outcomes in six adult medulloblastoma patients treated with VMAT-CSI (TRUEBEAM Varian) and surface-guided radiotherapy (Vision RT Ltd) No significant toxicities greater than G2 were observed during RT, and only two cases reported decreased platelet counts. The dose to the organs at risk was low and acceptable. The mean dose to the heart, lungs, eyes, stomach, and thyroid were 4.4 Gy, 8.5 Gy, 12 Gy, 8.7 Gy, and 11 Gy, respectively. In all translational directions, repositioning data was inferior to 2 mm in more than 90% of cases. Thanks to all Miulli.art Ilaria Bonaparte Fiorella Di Guglielmo Valerio Davì Roberta Carbonara Maria Paola Ciliberti Alessia Surgo Ente Ecclesiastico Ospedale Generale Regionale 'F. MIULLI' Medipass - Ergéa Group Università LUM

Inter-Fraction Motion and Dosimetric Analysis of Volumetric Modulated Arc Therapy for Craniospinal Irradiation in Adult Medulloblastoma Patients

Inter-Fraction Motion and Dosimetric Analysis of Volumetric Modulated Arc Therapy for Craniospinal Irradiation in Adult Medulloblastoma Patients

mdpi.com

To view or add a comment, sign in

Explore topics